KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Long-Term Deferred Tax (2016 - 2025)

Resmed (RMD) has disclosed Long-Term Deferred Tax for 16 consecutive years, with $285.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Deferred Tax rose 36.51% year-over-year to $285.9 million, compared with a TTM value of $285.9 million through Dec 2025, up 36.51%, and an annual FY2025 reading of $253.1 million, up 24.34% over the prior year.
  • Long-Term Deferred Tax was $285.9 million for Q4 2025 at Resmed, up from $275.9 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $285.9 million in Q4 2025 and bottomed at $49.9 million in Q1 2021.
  • Average Long-Term Deferred Tax over 5 years is $147.8 million, with a median of $135.6 million recorded in 2023.
  • The sharpest move saw Long-Term Deferred Tax soared 94.58% in 2021, then decreased 0.2% in 2022.
  • Year by year, Long-Term Deferred Tax stood at $74.7 million in 2021, then rose by 14.88% to $85.8 million in 2022, then soared by 81.8% to $156.0 million in 2023, then surged by 34.3% to $209.4 million in 2024, then soared by 36.51% to $285.9 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for RMD at $285.9 million in Q4 2025, $275.9 million in Q3 2025, and $253.1 million in Q2 2025.